Darryl Keith Rosencrants, Et Al. V. Danimer Scientific, Inc., Et Al. 21-CV-02708-Class Action Complaint

Total Page:16

File Type:pdf, Size:1020Kb

Darryl Keith Rosencrants, Et Al. V. Danimer Scientific, Inc., Et Al. 21-CV-02708-Class Action Complaint Case 1:21-cv-02708 Document 1 Filed 05/14/21 Page 1 of 30 PageID #: 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK DARRYL KEITH ROSENCRANTS, Case No. Individually and on Behalf of All Others Similarly Situated, CLASS ACTION COMPLAINT Plaintiff, v. JURY TRIAL DEMANDED DANIMER SCIENTIFIC, INC., STEPHEN E. CROSKREY, JOHN A. DOWDY, III, JOHN P. AMBOIAN, RICHARD J. HENDRIX, CHRISTY BASCO, PHILIP GREGORY CALHOUN, GREGORY HUNT, ISAO NODA, and STUART W. PRATT, Defendants. Plaintiff Darryl Keith Rosencrants (“Plaintiff”), individually and on behalf of all others similarly situated, by Plaintiff’s undersigned attorneys, for Plaintiff’s complaint against Defendants, alleges the following based upon personal knowledge as to Plaintiff and Plaintiff’s own acts, and information and belief as to all other matters, based upon, inter alia, the investigation conducted by and through Plaintiff’s attorneys, which included, among other things, a review of the Defendants’ public documents, conference calls and announcements made by Defendants, United States (“U.S.”) Securities and Exchange Commission (“SEC”) filings, wire and press releases published by and regarding Danimer Scientific, Inc. (“Danimer” or the “Company”), analysts’ reports and advisories about the Company, and information readily obtainable on the Internet. Plaintiff believes that substantial additional evidentiary support will exist for the allegations set forth herein after a reasonable opportunity for discovery. 1 Case 1:21-cv-02708 Document 1 Filed 05/14/21 Page 2 of 30 PageID #: 2 NATURE OF THE ACTION 1. This is a federal securities class action on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Danimer securities between December 30, 2020 and March 19, 2021, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. 2. Danimer was formerly known as “Live Oak Acquisition Corp.” (“Live Oak”), a publicly traded special purpose acquisition company (“SPAC”).1 In December 2020, Live Oak consummated a business combination with Meredian Holdings Group, Inc., doing business as Danimer Scientific (“Legacy Danimer”), a performance polymer company specializing in bioplastic replacements for traditional petrochemical-based plastics (the “Business Combination”). Following the Business Combination, Live Oak changed its name to “Danimer Scientific, Inc.,” changed its business to Legacy Danimer’s business, and replaced its management with Legacy Danimer’s management. 3. Since 2020, Legacy Danimer—and, following the Business Combination, Danimer—has sold polyhydroxyalkanoates (“PHAs”) commercially under its proprietary “Nodax” brand name for usage in a wide variety of plastic applications including water bottles, straws, and food containers, among others. The Company has touted Nodax as a 100% biodegradable, renewable, and sustainable plastic, which is purportedly superior to traditional plastics because of 1 An SPAC is a development stage company that has no specific business plan or purpose or has indicated its business plan is to engage in a merger or acquisition with an unidentified company or companies, other entity, or person. 2 Case 1:21-cv-02708 Document 1 Filed 05/14/21 Page 3 of 30 PageID #: 3 its advanced biodegradability. The Company attributes Nodax’s advanced biodegradability to microorganisms in nature that eat the bioplastic. 4. Weighing against the credibility of these claims is a troubled history of dubious business practices by Legacy Danimer’s—now Danimer’s—prior and current management. For example, the Company’s current Chief Executive Officer (“CEO”) and Chairman of the Board of Directors (“Chairman”), Stephen E. Croskrey (“Croskrey”), previously served as president of an armor company that paid $30 million to the U.S. Department of Justice (“DOJ”) to settle claims that the company knowingly manufactured and sold defective bullet-proof vests. Court documents indicate that Croskrey had attempted to cover up this fraud by threatening a supplier. Months before going public, Legacy Danimer also settled a lawsuit with its former CEO, alleging that he had fabricated his resume and entered into a fraudulent side agreement with a former director. Moreover, a Live Oak partner, Gary Wunderlich (“Wunderlich”), was previously accused by the SEC of aiding and abetting an entity’s violations of antifraud and compliance provisions. 5. Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Danimer had deficient internal controls; (ii) as a result, the Company had misrepresented, inter alia, its operations’ size and regulatory compliance; (iii) Defendants had overstated Nodax’s biodegradability, particularly in oceans and landfills; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times. 6. On March 20, 2021, the Wall Street Journal (“WSJ”) published an article entitled “Plastic Straws That Quickly Biodegrade in the Ocean, Not Quite, Scientists Say” addressing, among other things, Danimer’s claims that Nodax breaks down far more quickly than fossil-fuel 3 Case 1:21-cv-02708 Document 1 Filed 05/14/21 Page 4 of 30 PageID #: 4 plastics. The WSJ article alleged that, according to several experts on biodegradable plastics, “many claims about Nodax are exaggerated and misleading.” While Danimer reportedly asserts its claims are factual, the article cites at least one expert as stating that making broad claims about Nodax’s biodegradability “is not accurate” and is “greenwashing.” 7. On March 22, 2021, the first trading day following publication of the WSJ article, Danimer’s stock price fell $6.43 per share, or 12.87%, to close at $43.55 per share on March 22, 2021. 8. Following the end of the Class Period, on April 22, 2021, Spruce Point Capital Management (“Spruce Point”) published a report on Danimer, noting, among other red flags, various inconsistencies with Legacy Danimer’s (and Danimer’s) historical and present claims regarding the size of its operations, Nodax’s makeup and degradability, and the Company’s expected profitability. 9. Following publication of the Spruce Point report, Danimer’s stock price fell $2.01 per share, or 8.04%, to close at $22.99 per share on April 22, 2021. 10. Then, on May 4, 2021, Spruce Point published another report on Danimer alleging that the Company had “wildly overstated” production figures, pricing, and financial projections based on documents Spruce Point had acquired from the Commonwealth of Kentucky’s Department of Environmental Protection (“KDEP”) under the Freedom of Information Act (“FOIA”), all of which cast serious doubt on the integrity of the Company’s internal controls. 11. Following publication of this second Spruce Point report, Danimer’s stock price fell $1.49 per share, or 6.31%, to close at $22.14 per share on April 22, 2021. 4 Case 1:21-cv-02708 Document 1 Filed 05/14/21 Page 5 of 30 PageID #: 5 12. As a result of Defendants’ wrongful acts and omissions, and the precipitous decline in the market value of the Company’s securities, Plaintiff and other Class members have suffered significant losses and damages. JURISDICTION AND VENUE 13. The claims asserted herein arise under and pursuant to Sections 10(b) and 20(a) of the Exchange Act (15 U.S.C. §§ 78j(b) and 78t(a)) and Rule 10b-5 promulgated thereunder by the SEC (17 C.F.R. § 240.10b-5). 14. This Court has jurisdiction over the subject matter of this action pursuant to 28 U.S.C. § 1331 and Section 27 of the Exchange Act. 15. Venue is proper in this Judicial District pursuant to Section 27 of the Exchange Act (15 U.S.C. § 78aa) and 28 U.S.C. § 1391(b), as the alleged misstatements entered and the subsequent damages took place in this Judicial District. Pursuant to Danimer’s most recent annual report on Form 10-K, at March 26, 2021, there were 88,327,719 shares of the Company’s Class A common stock outstanding. Danimer’s Class A common stock trades on the New York Stock Exchange (“NYSE”). Accordingly, there are presumably hundreds, if not thousands, of investors in Danimer’s Class A common stock located within the U.S., some of whom undoubtedly reside in this Judicial District. 16. In connection with the acts alleged in this Complaint, Defendants, directly or indirectly, used the means and instrumentalities of interstate commerce, including, but not limited to, the mails, interstate telephone communications, and the facilities of the national securities markets. 5 Case 1:21-cv-02708 Document 1 Filed 05/14/21 Page 6 of 30 PageID #: 6 PARTIES 17. Plaintiff, as set forth in the attached Certification, acquired Danimer securities at artificially inflated prices during the Class Period and was damaged upon the revelation of the alleged corrective disclosures. 18. Danimer is a Delaware corporation with principal executive offices located at 140 Industrial Boulevard, Bainbridge, Georgia 39817. The Company’s Class A common stock and warrants trade in an efficient market on the NYSE under the ticker symbols “DNMR” and “DNMR WS,” respectively. 19. Defendant Croskrey has served as Danimer’s CEO and Chairman at all relevant times. 20. Defendant John A. Dowdy, III (“Dowdy”) has served as Danimer’s Chief Financial Officer at all relevant times. 21. Defendant John P. Amboian (“Amboian”) has served as a Director of Danimer at all relevant times. 22. Defendant Richard J. Hendrix (“Hendrix”) has served as a Director of Danimer at all relevant times. 23. Defendant Christy Basco (“Basco”) has served as a Director of Danimer at all relevant times.
Recommended publications
  • What's What and Who's Who in Compostable Products
    Compostable, Biodegradable Update BAGS, FOODSERVICE WARE, PACKAGING FILMS WHAT’S WHAT AND WHO’S WHO IN COMPOSTABLE PRODUCTS Demand for sustainable packaging, established standards for compostability and biodegradability, and increasing number of organics diversion programs are driving demand for compostable products. Nora Goldstein and Cristina Olivares HESE are, without a doubt, excit- products over the next few years. “So many ing times for companies in the factors are influencing the direction of bio- compostable products industry — materials,” says Bob Findlen, Vice-Presi- from the manufacturers of resins dent of Sales and Marketing of the Natural to the distributors of the end prod- Plastics polymer brand from Metabolix, Inc. ucts. After close to 20 years of “There is the concern around sustainability Tproduct and market development, a num- and the demand and activity that compa- ber of factors are converging to create de- nies like Wal-Mart are bringing to the mar- mand for compostable bags, foodservice ketplace. There is the biodegradability part ware, packaging films and containers. of the market to address issues like litter These include retailer demand for sustain- from traditional plastic bags. Environmen- able packaging, rising cost of petrochemi- tal issues are another driving factor, e.g., cals, expansion of food residuals compost- carbon balance, along with the unsustain- ing and zero waste initiatives, and, most ability of our thirst for oil. All these things recently, passage of an ordinance in San are happening, all at the same time. But Francisco to ban large grocery stores and have we reached a critical mass? If that is pharmacies from giving out traditional defined as starting to have an effect on the plastic shopping bags, which is expected to use of petroleum, we are not there yet.
    [Show full text]
  • Danimer Scientific Research Thesis 2021
    1 Full Legal Disclaimer This research presentation expresses our research opinions. You should assume that as of the publication date of any presentation, report or letter, Spruce Point Capital Management LLC (“SPCM”) (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our subscribers and clients has a short position in all stocks (and are long/short combinations of puts and calls on the stock) covered herein, including without limitation Danimer Scientific, Inc. (“DNMR”) and therefore stand to realize significant gains in the event that the price declines. Following publication of any presentation, report or letter, we intend to continue transacting in the securities covered therein, and we may be long, short, or neutral at any time hereafter regardless of our initial recommendation. All expressions of opinion are subject to change without notice, and Spruce Point Capital Management does not undertake to update this report or any information contained herein. Spruce Point Capital Management, subscribers and/or consultants shall have no obligation to inform any investor or viewer of this report about their historical, current, and future trading activities. This research presentation expresses our research opinions, which we have based upon interpretation of certain facts and observations, all of which are based upon publicly available information, and all of which are set out in this research presentation. Any investment involves substantial risks, including complete loss of capital. There can be no assurance that any statement, information, projection, estimate, or assumption made reference to directly or indirectly in this presentation will be realized or accurate. Any forecasts, estimates, and examples are for illustrative purposes only and should not be taken as limitations of the minimum or maximum possible loss, gain, or outcome.
    [Show full text]
  • What About Recycling of PHA-Polymers? Exploring the End-Of-Life Options of PHA
    The Global Organization for PHA - GO!PHA Oudebrugsteeg 9 [email protected] 1012JN Amsterdam www.gopha.org The Netherlands What about recycling of PHA-polymers? Exploring the end-of-life options of PHA GO!PHA White Paper #7 – 15 May 2020 Jan Ravenstijn, Co-founder of GO!PHA, Phil Van Trump, Chief Technology Officer, Danimer Scientific The PHA-platform consists of products that meet the needs of all known end-of-life options. In this article we shall explain the details behind this statement and its implications. In numerous countries and geographic areas people are rightfully fed-up with the plastic waste streams they see everywhere, including on land and in rivers, lakes and oceans. This plastic waste mountain is growing rapidly year after year. While the visible part of our plastic waste is readily apparent, the non-visible part is even larger. There are at least two main reasons driving the increased rate of this invisible waste: first, more than 90% of the plastic waste in our water streams sinks to the bottom due to fouling of the plastic waste surfaces; and second, plastic micro-particles from our clothes and a large variety of products we use daily not only end up in water streams, but also show up on land and in our food chain in unseen ways. Needless to say, action is long overdue. There are excellent initiatives in place to retrieve plastic waste from oceans and rivers, but that retrieval can lead to a simple recycling of those plastics to make articles that people then throw back into the oceans again.
    [Show full text]
  • DANIMER SCIENTIFIC, INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2021 DANIMER SCIENTIFIC, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 001-39280 84-1924518 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.) 140 Industrial Boulevard Bainbridge, Georgia 39817 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: 229 243-7075 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Trading Title of each class Symbol(s) Name of each exchange on which registered Class A Common stock, $0.0001 par value per share DNMR The New York Stock Exchange Warrants to purchase one share of Common Stock DNMR WS The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    [Show full text]
  • Complaint Danimer Scientific, Inc., Stephen for Violations of the E
    UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF GEORGIA ALBANY DIVISION __________, individually and on behalf of all others similarly situated, Plaintiff, Case No. v. CLASS ACTION COMPLAINT DANIMER SCIENTIFIC, INC., STEPHEN FOR VIOLATIONS OF THE E. CROSKREY, RICHARD HENDRIX, FEDERAL SECURITIES LAWS JOHN A. DOWDY, III, JOHN P. AMBOIAN, CHRISTY BASCO, PHILIP GREGORY CALHOUN, GREGORY JURY TRIAL DEMANDED HUNT, ISAO NODA, and STUART W. PRATT, Defendants. Plaintiff _______ (“Plaintiff”), by and through his attorneys, alleges upon personal knowledge as to his own acts, and upon information and belief as to all other matters, based upon the investigation conducted by and through his attorneys, which included, among other things, a review of documents filed by Defendants (as defined below) with the United States Securities and Exchange Commission (the “SEC”), news reports, press releases issued by Defendants, and other publicly available documents, as follows: NATURE AND SUMMARY OF THE ACTION 1. This is a securities class action on behalf of all investors who purchased or otherwise acquired Danimer Scientific, Inc. (“Danimer” or the “Company”) and/or Live Oak Acquisition Corp. (“Live Oak”)) securities between October 5, 2020 to May 3, 2021, inclusive (the “Class Period”). This action is brought on behalf of the Class for violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), 15 U.S.C. §§ 78j(b) and 78t(a) and Rule 10b-5 promulgated thereunder by the SEC, 17 C.F.R. § 240.10b-5. 2. According to its most
    [Show full text]
  • Investor Presentation
    Investor Presentation October 2020 Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful. This Presentation has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination between Live Oak Capital Corp. (“Live Oak”) and Danimer Scientific (“Danimer Scientific”) and the related transactions (the “Proposed Business Combination”) and for no other purpose. Neither the Securities and Exchange Commission nor any securities commission of any other U.S. or non-U.S. jurisdiction has approved or disapproved of the Proposed Business Combination presented herein, or determined that this Presentation is truthful or complete. Any representation to the contrary is a criminal offense. No representations or warranties, express or implied, are given in, or in respect of, this Presentation. To the fullest extent permitted by law in no circumstances will Live Oak, Danimer Scientific or any of their respective subsidiaries, stockholders, affiliates, representatives, directors, officers, employees, advisers, or agents be responsible or liable for a direct, indirect, or consequential loss or loss of profit arising from the use of this Presentation, its contents, its omissions, reliance on the information contained within it, or on opinions communicated in relation thereto or otherwise arising in connection therewith. Industry and market data used in this Presentation have been obtained from third-party industry publications and sources as well as from research reports prepared for other purposes.
    [Show full text]
  • Danimer Scientific Merger with Live Oak Acquisition Corp. Investor Conference Call Transcript October 5, 2020
    Danimer Scientific Merger with Live Oak Acquisition Corp. Investor Conference Call Transcript October 5, 2020 C O R P O R A T E P A R T I C I P A N T S Richard Hendrix, Chief Executive Officer, Live Oak Acquisition Corp. Stephen Croskrey, Chief Executive Officer, Danimer Scientific P R E S E N T A T I O N Operator Hello and welcome to the Live Oak Acquisition Corp and Danimer Scientific business combination announcement conference call. At this time, all participants are in a listen- only mode. If anyone should require operator assistance, please press star, one on your touch-tone telephone. There is a presentation that was publicly filed with the SEC that will accompany today’s discussion. The presentation can also be viewed on Live Oak’s website. Please refer to that as the Guide for today’s call. For everyone on the phone, Live Oak and Danimer Scientific will not be fieldinG any questions on today’s call. As a reminder, this conference is beinG recorded. Please note that we may discuss forward-lookinG statements within the meaninG of the Safe Harbor provisions of the Private Securities LitiGation Reform Act of 1995. These forward-lookinG statements include, amonG other thinGs, future results of operations, capacity, production and demand levels. Forward-lookinG statements are made based on our expectations and beliefs concerninG future events and therefore involve a number of risks and uncertainties. We caution that forward-lookinG statements are not Guarantees and that actual results could differ materially from those expressed or implied in the forward-lookinG statements.
    [Show full text]
  • Plastic the Way Nature Intended?
    POLYHYDROXYALKANOATES: PLASTIC THE WAY NATURE INTENDED? INDUSTRIAL AND ENERGY POLYHYDROXYALKANOATES: PLASTIC THE WAY NATURE INTENDED? WHITE PAPER EXECUTIVE SUMMARY Plastic accumulation in the natural environment is one of the most visible forms of environmental pollution caused by business. As a result of continual exposure to images of oceans full of plastic, consumers are becoming increasingly concerned about single-use disposable plastic items and plastic packaging. For brands and manufacturers, the search is on for alternatives in a wide range of applications. In particular, the superior to conventional plastics – solutions that bring all of the cost, high temperature performance of PHAs significantly extends marketing and convenience benefits of plastic, without the the addressable number of applications for bioplastics, environmental baggage. beyond those which can be served by the most common bioplastic PLA. Polyhyroxyalkanoates (PHAs) are a class of bio-derived, biodegradable polymers which could fit the bill. PHAs provide With costs now approaching parity with conventional a tunable property set which provides unparalleled potential polymers, overcoming manufacturing challenges is the last for a bioplastic to substitute fossil fuel derived plastics major hurdle preventing wide scale adoption of PHAs. 01 WHITE PAPER POLYHYDROXYALKANOATES: PLASTIC THE WAY NATURE INTENDED? PHAS ARE BIO-BASED, BIODEGRADABLE Bioplastics are bio-based, biodegradable or both (European Bioplastics) PLASTICS, PRODUCED BY FERMENTATION FROM BIO-BASED A RANGE OF FEEDSTOCKS, INCLUDING WASTE. Are bio-based Are biodegradable and bio-based The term bioplastics is an umbrella term which describes: Bioplastics Bioplastics e.g. Bio-based PE e.g. PLA, PET, PTT PHA, PBS, conventional polymers derived all or in part using drop-in, Starch blends bio-based feedstocks, NOT BIODEGRADABLE BIODEGRADABLE polymers which are fossil fuel derived but are biodegradable Conventional plastics Bioplastics nearly all conventional e.g.
    [Show full text]
  • Insert Title of Presentation Here
    Insert Title of Presentation 2018 BIO World Congress Here danimerscientific.com An Alternative to Traditional Non-Degradable Plastics Used in Everyday Life Phil Van Trump Chief Technology Officer Insert Title of Presentation Who We Are Here danimerscientific.com Danimer Scientific was started in 2004, located in Bainbridge GA We are a global leader in Biopolymer research, development & commercialization We produce 100% certified biodegradable and compostable replacements for many types of petroleum based plastics that are both renewable & sustainable Lead by example – practicing a truly “Renewable & Sustainable” model Contributing to the new Bio Economy Insert Title of Presentation Bainbridge, GA Plant Here danimerscientific.com www.danimerscientific.com Petroleum Plastic at a Glance • 685 billion lbs of plastics made each year • 35 billion water bottles discarded each year • Average working life of a plastic bag is 15 minutes • Only 8% of plastics in North America are recycled • Oceans are contaminated with tiny plastics particles Danimer Scientific | Plastics Overview www.danimerscientific.com Danimer Scientific Technologies Technology Platforms: • Functionalize Biopolymers such as PLA • Produce unique monomers – “building blocks” • Produce biopolymers such as PBS and PBSA • Condensation and ROP Polymers • Produce PHA polymers through a fermentation process • Manufacture “finished pellet” for conversion that meets customer requirements • As a global leader in biopolymer innovation, DaniMer’s diversified technology platform enables a wide range of solutions to our customers and partners. Danimer Scientific | Technologies Insert Title of Presentation Danimer Scientific’s Nodax™ PHA Here danimerscientific.com Polyhydroxyalkanoates (PHAs) O • Semi-crystalline, biodegradable, thermoplastics polyester n R O • Produced by microorganisms PHA R group PHB -CH3 PHV -CH2CH3 -CH , -CH CH PHBV (BiopolTM) 3 2 3 PHBHx -CH3,-CH2CH2CH3 PHBO -CH3, -(CH2)4CH3 PHBD -CH3, -(CH2)6CH3 etc.
    [Show full text]
  • Danimer Complaint
    Case 1:21-cv-00095-LAG Document 1 Filed 05/18/21 Page 1 of 34 UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF GEORGIA ALBANY DIVISION CARLOS CABALLERO, on behalf of himself and all others similarly situated, Civ. A. No. 1:21-cv-_________ Plaintiff, COMPLAINT - CLASS ACTION v. DANIMER SCIENTIFIC, INC., JURY TRIAL DEMANDED STEPHEN E. CROSKREY, and JOHN A. DOWDY III, Defendants. Case 1:21-cv-00095-LAG Document 1 Filed 05/18/21 Page 2 of 34 TABLE OF CONTENTS I. INTRODUCTION ............................................................................. 1 II. JURISDICTION AND VENUE ........................................................ 6 III. PARTIES ........................................................................................... 7 IV. BACKGROUND ............................................................................... 8 V. DANIMER DEFRAUDS INVESTORS ........................................... 11 VI. DISCLOSURES OF DANIMER’S MISCONDUCT CAUSE SIGNIFICANT INVESTOR LOSSES .............................................. 19 VII. LOSS CAUSATION ......................................................................... 22 VIII. CLASS ACTION ALLEGATIONS .................................................. 22 IX. INAPPLICABILITY OF STATUTORY SAFE HARBOR ............. 24 X. PRESUMPTION OF RELIANCE .................................................... 25 XI. COUNT I ........................................................................................... 27 XII. COUNT II .........................................................................................
    [Show full text]
  • Investor Presentation
    Investor Presentation October 2020 Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful. This Presentation has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination between Live Oak Capital Corp. (“Live Oak”) and Danimer Scientific (“Danimer Scientific”) and the related transactions (the “Proposed Business Combination”) and for no other purpose. Neither the Securities and Exchange Commission nor any securities commission of any other U.S. or non-U.S. jurisdiction has approved or disapproved of the Proposed Business Combination presented herein, or determined that this Presentation is truthful or complete. Any representation to the contrary is a criminal offense. No representations or warranties, express or implied, are given in, or in respect of, this Presentation. To the fullest extent permitted by law in no circumstances will Live Oak, Danimer Scientific or any of their respective subsidiaries, stockholders, affiliates, representatives, directors, officers, employees, advisers, or agents be responsible or liable for a direct, indirect, or consequential loss or loss of profit arising from the use of this Presentation, its contents, its omissions, reliance on the information contained within it, or on opinions communicated in relation thereto or otherwise arising in connection therewith. Industry and market data used in this Presentation have been obtained from third-party industry publications and sources as well as from research reports prepared for other purposes.
    [Show full text]
  • WO 2016/029024 Al 25 February 2016 (25.02.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/029024 Al 25 February 2016 (25.02.2016) P O P C T (51) International Patent Classification: (74) Agents: CANTRELL, Quentin, G. et al; Woodard, Em- B65D 27/00 (2006.01) B65D 65/46 (2006.01) hardt, Moriarty, Mcnett & Henry LLP, 111 Monument B65D 33/00 (2006.01) B65D 81/38 (2006.01) Circle, Suite 3700, Indianapolis, IN 46204 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US20 15/046 125 kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (22) Date: International Filing BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 20 August 2015 (20.08.2015) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (26) Publication Language: English MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (30) Priority Data: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 14/464,281 20 August 2014 (20.08.2014) US SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant: FRONTIER PAPER & PACKAGING, INC.
    [Show full text]